Compare GERN & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GERN | LSPD |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | United States | Canada |
| Employees | 229 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2020 |
| Metric | GERN | LSPD |
|---|---|---|
| Price | $1.68 | $9.54 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 10 |
| Target Price | $2.17 | ★ $13.20 |
| AVG Volume (30 Days) | ★ 19.2M | 838.1K |
| Earning Date | 05-06-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.91 | $15.43 |
| Revenue Next Year | $43.75 | $10.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $8.37 |
| 52 Week High | $2.01 | $14.34 |
| Indicator | GERN | LSPD |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 61.73 |
| Support Level | $1.24 | $8.48 |
| Resistance Level | $1.72 | $9.71 |
| Average True Range (ATR) | 0.10 | 0.32 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 64.14 | 92.61 |
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.